TotalMarketCap

Bone Biologics

BBLGNasdaq United StatesHealth CareIndustrial Specialties

Market cap

$1.093 M

$0.32 -8.97%

Close of 6 Nov 2026

As of 6 Nov 2026, Bone Biologics (BBLG) has a market capitalization of $1.09M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$3.11M

Loss-making

Shares outstanding

3,389,057

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Industrial Specialties, ranked by market cap

All 55 →
  1. #51Cuprina Holdings (Cayman)CUPR$13.5M
  2. #52HeartSciencesHSCS$12.8M
  3. #53CollPlant BiotechnologiesCLGN$12.4M
  4. #54Regentis BiomaterialsRGNT$8.43M
  5. #55Bone BiologicsBBLG$1.09M

What if Bone Biologics were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,331,778

Per share 25,834,971× higher

Bitcoin $1.53T

$450,818.00

Per share 1,397,885× higher

Apple $5.02T

$1,479,993

Per share 4,589,127× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Bone Biologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.